Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$141.59 - $168.66 $274,826 - $327,369
-1,941 Reduced 32.94%
3,952 $617,000
Q1 2022

May 12, 2022

SELL
$129.64 - $160.7 $5 Million - $6.19 Million
-38,540 Reduced 86.74%
5,893 $918,000
Q4 2021

Jan 25, 2022

SELL
$119.87 - $145.67 $125,863 - $152,953
-1,050 Reduced 2.31%
44,433 $5.66 Million
Q3 2021

Nov 04, 2021

BUY
$128.64 - $184.79 $10,162 - $14,598
79 Added 0.17%
45,483 $5.92 Million
Q2 2021

Aug 09, 2021

SELL
$160.2 - $186.42 $4.21 Million - $4.9 Million
-26,302 Reduced 36.68%
45,404 $8.07 Million
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $74,344 - $85,882
495 Added 0.7%
71,706 $11.8 Million
Q4 2020

Feb 09, 2021

SELL
$140.71 - $165.05 $139,865 - $164,059
-994 Reduced 1.38%
71,211 $11.8 Million
Q3 2020

Nov 05, 2020

SELL
$105.46 - $144.13 $581,506 - $794,732
-5,514 Reduced 7.09%
72,205 $10.3 Million
Q2 2020

Jul 30, 2020

BUY
$95.68 - $121.88 $1.38 Million - $1.76 Million
14,434 Added 22.81%
77,719 $8.58 Million
Q1 2020

May 08, 2020

BUY
$87.74 - $152.74 $2.54 Million - $4.43 Million
28,985 Added 84.5%
63,285 $6.31 Million
Q4 2019

Feb 06, 2020

BUY
$117.65 - $153.73 $81,884 - $106,996
696 Added 2.07%
34,300 $5.12 Million
Q3 2019

Oct 29, 2019

BUY
$125.18 - $143.24 $3.71 Million - $4.24 Million
29,599 Added 739.05%
33,604 $4.31 Million
Q2 2019

Aug 29, 2019

BUY
$125.55 - $144.48 $2,134 - $2,456
17 Added 0.43%
4,005 $571,000
Q1 2019

May 13, 2019

BUY
$121.81 - $142.95 $27,529 - $32,306
226 Added 6.01%
3,988 $570,000
Q4 2018

Feb 15, 2019

BUY
$115.94 - $166.74 $8,927 - $12,838
77 Added 2.09%
3,762 $466,000
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $593,321 - $665,400
3,685 New
3,685 $620,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.